Many Texas Docs Not Pushing HPV Vaccine for Girls
Study finds fewer than half always recommend the shots, despite federal guidelines
THURSDAY, Aug. 6 (HealthDay News) -- More than half of Texas doctors don't always recommend human papillomavirus (HPV) vaccination for girls, despite U.S. guidelines urging their inoculation, a new surv...
Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer
Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer have found that head and neck cancer patients who test positive for the human papillomavirus (HPV) have much better survival rates than patients who don't have the virus, according to a new study in the journal Cancer...
New Evidence Supports HPV Vaccine
Industry-funded study showed high levels of protection against human papillomavirus
MONDAY, July 6 (HealthDay News) -- The human papillomavirus (HPV) vaccine is highly effective at preventing precancerous cervical lesions that can lead to cervical cancer, a new study shows.
Study: Benefit to women not enough to sway men to get HPV vaccine
TALLAHASSEE, Fla. -- Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida St...
Sexually Transmitted HPV Linked to Certain Head & Neck Cancers
BUFFALO, N.Y., May 22 /PRNewswire-USNewswire/ -- Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV
16 to prevent head & neck cancers. The call comes amid growi...
Kaiser Permanente Data Provides Strong Evidence for Continued Value of Combined Pap and HPV Testing
Evaluation of 800,000 Pap and HPV
cotests concludes that "concerns about excessive HPV
test positives...are not borne out"
VENLO, The Netherlands, March 24 /PRNewswire/ -- Physicians from Kaiser Permanente and the National Cancer Institute report in the March issue of Obstetrics & Gyneco...
FDA Approves Two Hologic HPV Tests
HR: First FDA approved high-risk HPV
test in a decade
16/18: First HPV
DNA genotyping test approved by the FDA
BEDFORD, Mass., March 13 /PRNewswire-FirstCall/ -- Hologic, Inc., (Hologic or the Company) (Nasdaq: HOLX ), a leading women's healthcare company dedi...
Both Latino and non-Latino women likely to accept HPV vaccination for selves and children
Most women responding to a survey conducted at Massachusetts General Hospital (MGH) clinics indicated they would be willing to be vaccinated against the human papillomavirus (HPV) and to have their daughters and even sons vaccinated in order to prevent cancer in their children. The report in the ...
1 in 4 California adolescent girls has had HPV vaccine
Less than two years after the HPV
vaccine was approved as a routine vaccination for girls aged 11 and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, which is strongly linked to cervical cancer.
Additionally, a maj...
New Local TV Ad Campaign To Educate St. Louis Women About Cervical Cancer Prevention and HPV Testing
ST. LOUIS, Feb. 9 /PRNewswire/ -- Through a new advertising campaign being launched in St. Louis today, local women will soon learn more about cervical cancer screening and prevention. Cervical cancer is caused by high-risk types of the human papillomavirus (HPV) and QIAGEN, the maker of the only...
HPV in Medical Technology
Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention
Paper is First in a Series Based on Presentations from Cervical Cancer Prevention Forum Hosted by SGO
CHICAGO, Aug. 3 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer i...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
SAN DIEGO and ANN ARBOR, Mich., July 13 /PRNewswire-FirstCall/ -- Results from a study published by the University of Michigan have shown that as many as 15% of women in the study group determined to be negative for the presence of human papillomavirus (HPV) in the cervix, via ...
SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems
HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its involvement in Hologic's (formerly Third Wave Technologies) successful clinical trials of two Human Papillomavirus (HPV) in vitro diagnostic tests. SeqWright p...
Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
QIAGEN donates one million tests to expand access to HPV
screening in the world's poorest countries
VENLO, Netherlands, April 1 /PRNewswire-FirstCall/ -- Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of Medicine (NEJM) demonst...
Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
BEDFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Hologic, Inc.
(Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium
diagnostics, medical imaging systems and surgical products dedicated to
serving the healthcare needs of women, today announced the results of the
First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
QIAGEN's careHPV test provides 'substantially more accurate' front-line screening
VENLO, Netherlands, Sept. 21 /PRNewswire-FirstCall/ -- A new HPV
developed by QIAGEN specifically for use in regions of the world with
scarce resources is "substantially" more a...
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
HILDEN, Germany, May 21 /PRNewswire-FirstCall/ --
- Research Supports Replacement of Pap With HPV
Test as Front-line
Long-term data from a study published in the International Journal of
Cancer show that women screened only with a human papillomavirus (HPV) DNA
test are half as like...
The Oral Cancer Foundation Urges HPV Vaccination for Males
For the public health, we need to fast-track research and approvals
now, says foundation
NEWPORT BEACH, Calif., Oct. 24 /PRNewswire-USNewswire/ -- On the heels
of a study published this month in the journal Cancer, and recent
supporting science related to HPV
and oral cancer in the New Engla...
Data Published in The Lancet Show Gardasil was 100 Percent
Effective in Preventing High-Grade Vulvar and Vaginal Lesions
Caused by HPV Types 16 and 18
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--May 17, 2007 - Results
published this week in The Lancet show that Merck's cervical cancer
vaccine, GARDASIL (Quadrivalent Human Papillomavirus (Types 6, 11,
16, 18) Recombinant Vaccine) was 100 percent effective in
preventing high-grade vulvar and vaginal...
Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
...that the vaccine provides cross-protection against hpv
types 31, 33 and 45, the three most common cancer-...firm the efficacy offered by Cervarix (R) against hpv
16 and 18. For the first time the results show tha...epithelial neoplasia 2+ or CIN 2+) associated with hpv
16 or 18. A further analysis of the same cohort wh...
HPV in Medical Dictionary
...remover on drugstore.com. We also have a wide selection of foot care, medicine cabinet products online at drugstore.com. Warts, wart treatment, hpv
warts, hiv warts, genital warts, anal warts, plantar warts, subungal warts, ... warts heal from removal the wart it is probably not ... ...
...gn tumors of the epidermis caused by a virus. ... Different sub-types of hpv
cause different types of warts . ... Information on the warts , also ... hundreds. ... Warts are the most easily recognized sign of genital hpv
infection. ... Genital warts often occur in clusters and can be very tiny...
... it removed. ... Wart - Definition of Wart at Dictionary.com a free online dictionary with ... Medically Proven Wart Removal Cream Kills the hpv
Virus. Try it,Today! www.WartCream.com ... Warts are simply areas of skin that grow faster than normal due to the presence of the wart virus...
...-track the ... Some doctors worry about the high costs for the new immunization. ... The new vaccine is 100% effective against four strains of hpv
associated with 70 ... ...
...g a vaccination program, veterinarians consider the pet's lifestyle, ... in the case of vaccination , serious adverse responses are very ... An hpv
vaccination drive for women ages 9 to 26 will take place from 5 to 7 p.m. ... The free vaccination is not based on income. ... UNIVERSAL HEPAT...
...ts the epidermis and mucous membranes of humans. hpv
can lead to cancers of the cervix, vulva, vagina...on of the human ... hpv, cervical cancer, hpv
test, pap smear,...
...isual inspection and may be confirmed by ... hpv
- What is genital hpv
infection? How common is it? How does hpv
cause genital warts and cancer? ... If left ...
...ervix Center at Johns Hopkins coordinates all aspects of care of women with hpv
disease. ... Most cervical cancers are squamous cell carcinomas and ....... ... What is cervical dysplasia ? How can a person get the types of hpv
that cause cell changes? ... treatment may not even be necessary for mi...
...ypical and malignant glandular cells ... Most cervical cancer is caused by a virus called human papillomavirus, or HPV. ... Not all types of hpv
cause cervical cancer. ... Cervical spondylosis — Comprehensive overview covers symptoms, treatment of neck osteoarthritis. ... Also known...
HPV in Biological News
More than half of Texas physicians do not always recommend HPV vaccine to girls
PHILADELPHIA - The Advisory Committee on Immunization Practices recommends the human papillomavirus vaccination for all 11- and 12-year-old girls, but results of a recent survey showed that more than half of Texas physicians do not follow these recommendations.
The survey was published in Can...
African-Americans aware and accepting, but often do not receive, the HPV vaccine
CAREFREE, A.Z. - Although only 25 percent of eligible African-American adolescents have received the HPV
vaccine, a new survey presented at the American Association for Cancer Research conference on the Science of Cancer Health Disparities, suggests they have a positive view of the treatment and m...
Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer. Results of a nationwide study of the vaccine will be published in the May 9 issue of the New England Journal of Me...
New test for most virulent HPV strains under study
A test for the two strains of human papillomavirus responsible for most cervical cancers is under study.
The molecular assay uses a cervical scraping, like that for a liquid-based Pap smear, to test for HPV
types 16 and 18, responsible for 70 percent of cervical cancers, says Dr. Daron G. Ferris...
High HPV concentrations combined with smoking significantly raise risks of cervical cancer
Cigarette smoking and concurrent infection with high levels of the virus associated with cervical cancer can increase cancer risk by as much as 27 times, according to a study published in the November 2006 issue of Cancer Epidemiology, Biomarkers & Prevention.
Anthony Gunnell, a medical bios...
Handling HPV vaccines and screening: The views of 100 authors
Amsterdam, 21 September, 2006 - Elsevier is delighted to announce the publication of a unique supplement to the journal Vaccine: HPV
Vaccines and Screening in the Prevention of Cervical Cancer. This special monograph provides a comprehensive and invaluable update for paediatricians, gynaecologists,...
Higher risk for cervical cancer seen among women infected with multiple HPV types
Although doctors have known that the cervical tissue at the opening to the womb can harbor multiple HPV
types, this study is the first to document that the risk for developing cervical cancer, the second most common form of cancer in women worldwide, is higher in females infected with multiple HPV
Parents need to be educated about HPV vaccinations for daughters
London, UK: Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine heard today (Thursday 30 March).
Updated data on novel HPV vaccine confirms efficacy in large population
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer, according to a study presented today during the American Association for Cancer Research's 4th Annual Frontiers in...
NIH funds $9.5 million for research on HIV and the human innate immune system
...ng human papillomavirus (HPV). This virus is more frequently associated with the genital tract and is now being seen in the mouth. Warts produced by hpv
can lead to cancer and increased oral infections.
"What is resolving one problem is setting off another," says Weinberg. "However, outcomes of ou...
HPV in Biological Technology
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Gen-Probe's (Nasdaq: GPRO )
CE-marked APTIMA(R) HPV
assay may be an important new molecular tool to more
accurately detect high-risk human papillomavirus (HPV) infections that are
associated with cervical cancer or precancerous lesions, according to n...
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(Nasdaq: GPRO ) announced today that the Company has launched in Europe its
Assay, a highly specific molecular diagnostic test to detect
high-risk strains of the human papillomavirus (HPV), which causes cervical
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
Quantitative Detection of HPV
Viral Load a Possible Indicator of Cervical Cancer Risk
SUNNYVALE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced that it has entered into an agreement to exclusively
license the Human Papillomavirus (...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...test that the company develops.
Test - In July, the University of Michigan publis... promising results in the use of the AttoSense(TM) hpv
test in the Journal of Virological Methods. Result...in the cervix, via the most commonly used test for hpv
DNA, may actually be infected with the virus at cl...
QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
...NA testing technology (also known as the digene(R) hpv
Test) to screen
women for cancer-causing types of hpv
to identify those with or at risk for
developing c...ected to be screened in June.
The impact of hpv
testing on cervical cancer incidence and death in ...
CBDM.T, The Market and Business Intelligence Company Reviews The Vaccine Market
...cines represent one of the fastest growing pharmaceutical product categories at over 17% per annum to 2012. This is driven largely by strong growth of hpv
vaccines (Human Papilloma Virus,Cervarix and Gardasil), paediatric vaccines (Rotarix) launched into developing markets and meningitis vaccines (Prevna...
Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
...ver 20 years, has been widely used by physicians as a treatment for certain hpv
induced lesions, but is not generally favored due to the fact that conventi...intradermal injection is restricted to visible lesion administration, while hpv
infection is often characterized by both visible and non-visible (i.e., sub...
PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies
for immunotherapeutic applications.
Versamune(TM)-HPV is an immunotherapy drug which has demonstrated
significant promise in curing hpv
infection and HPV-related cancer in
preclinical animal and human model studies. Cancers caused by infection with
the human papilloma virus (HPV) incl...
Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
...fective technologies for screening - including
Infection with the papillomavirus is...rd: QIA), the company that developed
the digene(R) hpv
Test, which will be used in the SSA's program and ...men whose smears had
appeared normal. In contrast, hpv
testing detects the presence of the virus
Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
...proved cures for either condition. Early preclinical data suggest that Hsp 6/11 has the ability to elicit strong T-cell responses against hpv
types 6 and 11 target antigens.
"During the quarter, Nventa announced positive clinical results for our
lead candidate, HspE7, presented impor...
HPV in Biological Dictionary
... ... Information on vaccines , and the immunization policies and practices that affect the children and adults of Texas. ... The new controversial hpv
vaccine ... The National Vaccine Program Office provides information about vaccines , influenza, immunization, and international portation of ...
..."the volcano ... Find deals and discount prices on seed dormancy at Smarter. Shop online, compare products, and save. ... on Corn seed and hpv
Dormancy Period ... Plant dormancy . Maize Plant. Soybean seed. Germination. Plant growth ... © 2009 dormancy .com. All Rights ... Seed dorman...